Age at diagnosis, yrs, mean ± SD | |
Male | 59.6 ± 15.5 |
Female | 53.5 ± 14.0 |
All | 54.1 ± 14.3 |
Age groups, male, yrs, n (%) | |
0–9 | 2 (0.1) |
10–19 | 9 (0.5) |
20–29 | 62 (3.6) |
30–39 | 128 (7.4) |
40–49 | 278 (16.1) |
50–59 | 349 (20.2) |
60–69 | 372 (21.5) |
70–79 | 406 (23.5) |
≥ 80 | 121 (7.0) |
All | 1727 (100) |
Age groups, female, yrs, n (%) | |
0–9 | 6 (0.04) |
10–19 | 109 (0.8) |
20–29 | 656 (4.7) |
30–39 | 1627 (11.7) |
40–49 | 3041 (21.9) |
50–59 | 4083 (29.4) |
60–69 | 2563 (18.4) |
70–79 | 1480 (10.6) |
≥ 80 | 344 (2.5) |
All | 13,909 (100) |
Duration of followup, yrs, mean ± SD | |
Male | 5.6 ± 3.8 |
Female | 5.6 ± 3.6 |
All | 5.6 ± 3.6 |